Get a reply from this employer — a resume and cover letter tailored to exactly what they’re hiring for.
GSK in Pakistan invites applications for an ACCA Trainee in the Site Finance team. You will support financial analysis, month-end close, and reporting while learning IFRS and controls.
Fresh to 2 years’ experience, SAP experience, strong Excel and communication will help you grow through the ACCA journey in a global biopharma company.
You will join our Site Finance team as an ACCA Trainee. You will support financial analysis, reporting, month-end close and accounting tasks. You will work closely with finance colleagues across sites and with business partners. We value curiosity, attention to detail and a drive to learn. This role gives you meaningful exposure to finance in a global company and strong development for your ACCA journey. Join us to apply your skills, grow quickly, and help us unite science, technology and talent to get ahead of disease together.
ACCA (Qualified/ Part Qualified) is required for this role.
Fresh to 2 years of relevant accounting or finance experience.
Experience with ERP systems such as SAP.
Good working knowledge of Microsoft Excel.
Strong verbal and written communication skills.
Knowledge of accounting standards and basic understanding of IFRS.
Comfortable working with financial reporting tools and data extraction.
Demonstrated problem solving and a proactive approach to learning.
Business Reporting Tools, Data Storytelling, Digital Fluency, Financial Modeling, Financial Performance Improvement, Influencing Without Authority, Insight Generation, Problem Solving
Uniting science, technology and talent to get ahead of disease together.
GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases - to impact health at scale.
People and patients around the world count on the medicines and vaccines we make, so we're committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.